A 2022 Rosenman Innovator, Zenflow, closed a $24 million Series C funding round. The funds will support the FDA Pre-Market […]
Zenflow Secures $24M Funding to Advance FDA Filing and Commercialization of BPH Treatment

A 2022 Rosenman Innovator, Zenflow, closed a $24 million Series C funding round. The funds will support the FDA Pre-Market […]
2019 Rosenman Innovator, Bloomlife, has raised $12.2M in Series A funding to advance its maternal health technology platform. The company […]
MD Ally, a healthcare navigation company transforming 911 systems and 2021 ADAPT Awardee, has raised $14 million in Series A […]
Renata Medical, a 2020 Rosenman Innovator, has received FDA approval for its Minima Growth Stent, designed specifically for pediatric patients […]
Seven Starling, 2023 ADAPT Finalist, has successfully closed an oversubscribed $10.9M Series A funding round, aimed at expanding its specialized […]
XP Health, a Rosenman ADAPT Awardee and leader in digital-first vision care, has secured $33.2 million in Series B funding […]
Oshi Health, a Rosenman Institute 2020 ADAPT Awardee, announced the successful close of a $60M Series C funding round. Oshi […]
Summer Health, a Rosenman Institute 2023 ADAPT finalist, has secured $12M in Series A funding, co-led by 7wire Ventures and […]
Earlier this year, Neurovalens announced the 2022 Rosenman Innovator has received medical device clearance from the FDA to treat anxiety […]
The 2023 ADAPT Finalist has raised a $14 million Series A funding round to enhance Backpack Healthcare’s technology platform, expand […]